Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
128 hedge funds and large institutions have $520M invested in Intersect ENT, Inc in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 58 increasing their positions, 18 reducing their positions, and 10 closing their positions.
310% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 10
222% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 18
88% more capital invested
Capital invested by funds: $277M → $520M (+$244M)
32% more funds holding
Funds holding: 97 → 128 (+31)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$25.1M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$22.7M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
+$16.2M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$15.3M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NVPX
Norwest Venture Partners XI
Palo Alto,
California
|
-$5.88M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.85M |
| 3 |
JP Morgan Chase
New York
|
-$2.73M |
| 4 |
Millennium Management
New York
|
-$2.59M |
| 5 |
CCI
Columbus Circle Investors
|
-$2.37M |
XENT Hedge Fund Activity: Q2 2015 in Review
128 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2015, worth a combined $520M — up 88% from $277M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new XENT positions and 10 closed out — a net gain of 31 holders — while 58 added to existing stakes and 18 trimmed.
The largest buyer was Jennison Associates, adding an estimated $25.1M. The largest seller was Norwest Venture Partners XI, cutting an estimated $5.88M.
- 128 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2015, up from 97 in Q1 2015.
- Funds reported $520M of Intersect ENT, Inc stock for Q2 2015, up 88% quarter-over-quarter.
- 41 funds opened new Intersect ENT, Inc positions in Q2 2015 and 10 closed out, a net change of +31 holders.
- The largest Intersect ENT, Inc buyer in Q2 2015 was Jennison Associates, an estimated $25.1M added.
- The largest Intersect ENT, Inc seller in Q2 2015 was Norwest Venture Partners XI, an estimated $5.88M sold.
Based on aggregated 13F filings for Q2 2015.